Therefore, IDH wild-type GBMs are more aggressive as compared to IDH-mutated GBMs; the latter is usually a secondary GBM and/or a low-grade glioma, such as oligodendroglioma and pediatric glioma, associated with a better prognosis [53]. This evidence concerns the gene IDH1 and glioma.